Estimation of Cumulative Activity of ¹⁷⁷Lu-Cetuximab from a Single Diagnostic ⁶⁴Cu-Cetuximab Scan.

Publié en May 2022 Cancer biotherapy & radiopharmaceuticals

⁶⁴Cu-/¹⁷⁷Lu-Cetuximab Theranostic Pair: May the Single ⁶⁴Cu-Cetuximab Diagnostic Scan Be Acquired at Any Time After Injection?

Cancer biotherapy & radiopharmaceuticals

Previous publication

On Semiquantitative Methods for Assessing Vascular ¹⁸F-FDG PET Activity in Large-Vessel Vasculitis.

Cancer biotherapy & radiopharmaceuticals

Next publication